Matt Calkins
Analyst · Morgan Stanley. Please proceed with your question
Thank you, Kevin, and thank you all for joining us today. In the fourth quarter of 2017 Appian subscription revenue grew 42% year-over-year to $23.5 million. Our non-GAAP loss from operations was $4.9 million compared to the loss of $1.8 million in the prior year quarter. We were cash flow positive in Q4 generating $1 million in cash flow from operations. Our subscription revenue retention remained high at 122% as of December 31, 2017. Our professional services revenue was also high at $25.2 million, with non-GAAP gross margin of 37%. For the full-year subscription revenue grew by 38% to $82.2 million. And finally, of net new subscription customers for all of 2017 we added 85 versus 28 in the prior year and these results exceeded our guidance. Appian's growth in 2017 has a lot to do with being in the right place being well-positioned. The positioning is very simple. Company's today need to build unique software applications. Traditional methods are expensive in slot, Appian has an easy answer. We let customers draw an application like a flowchart rather than coded. We let them assemble an application from pre-made objects like reusable Lego bricks. This approaches 6 to 20 times faster than a regular development, best of all the applications built on our platform are powerful, they're scalable, secure, cloud ready, highly available and native on all major mobile devices. Appian applications run banks, airports, insurers, retailers, et cetera. We're making it easy to build unique industrial strength software that's an ability the world is excited to buy right now. Our goal in 2018 is to bring this simple winning proposition to more customers. We're learning a lot about how large organizations want to build and use unique software. We channel this knowledge back into vertical marketing and sales campaigns some of which showed great success in 2017. In pharma, for example, we grew subscription revenue 53% over the full-year. Currently six of the top 10 pharma companies use Appian to manage critical business processes like clinical trials management and pharmacovigilance. In Q4 we had new and expansion wins at three of the top five global pharmaceutical companies and pharma subs revenue grew 70% versus the prior year period. The first of these large wins was a significant expansion deal at an existing $1 million per year customer. With this deal, which doubles their annual spend less, they'll now use Appian to deliver new medical devices to market, replacing a sprawl homegrown apps and spreadsheets. Among the significant new name wins with the European multinational pharmaceutical customer who plans to use Appian to manage its pharmacovigilance process. Their application will manage drug safety reporting and replace a disjointed mix of systems including Microsoft SharePoint, Lotus Notes, databases, and email. We were selected over two large competitors because we successfully delivered a powerful application during a two day proof of concept. Following the win, we developed and deployed a full solution in nine weeks. I mentioned this to highlight our speed edge, we're fast to show value and the two-day POC or Proof Of Concept suits us very well, but we're also remarkably quick to get full applications into production. Our European investments over the past few years bear fruit in 2017. In Q4, European revenue was 20% of total revenue as compared to 11% in the prior year period. For all of 2017, European subscription revenue rose 91% and total revenue doubled year-over-year. Notably Europe, Europe also provided 32 net new subscription customers in 2017. In Europe, we gained one of the world's major beverage companies as a new customer in Q4. They wanted to replace their restaurant leasing system currently running on paper, Excel, and email, with a more scalable and transparent solution. They choose Appian over two large competitors after we showed superior alignment with their team and a fully integrated application in a short proof of concept. We also had a number of key Q4 expansion deals in Europe. We won a multi-million dollar deal at MHRA, a governmental agency in the United Kingdom. We added million dollar follow-on deals at two of the top 20 global banks and at GRDF, an energy service company that serves 90% of the gas market in France. GRDF became a customer in 2015 with a purchase of 2500 user licenses. Over the last two and half years, they've expanded their use of Appian by building more applications and adding more users opportunistically. With our platform, they have improved service to their 11 million customers by better managing gas supplier requests, energy loss, gas and network extensions, and meter connections. In 2017, GRDF wanted a more strategic relationship and to use Appian globally, so they increased their investment to allow them to grow to 10,000 users. Perhaps the most important trend in our business today is the one towards stronger partnerships. Partners are sourcing more business for us. In 2017, the total value of partner preferred deals was three-and-a-half times as much as in 2016. Partners brought us 30 new customers last year which was more than Appian's total increase in new customers in 2016. Here is a quick example to show how partner relationships facilitate our growth in new places. In Q4, we pursued a million dollar deal in Poland with a large global bank. They wanted to modernize their operations on a platform with strong robotic process automation and case management capabilities we're leaders in both of those markets, so we're an excellent fit. But because Poland is new to us, we relied on Deloitte's strong local presence and capabilities. Our technical strength and our partnership with Deloitte won this deal against two major competitors. In addition to significantly increasing our subscription customer base in 2017, we were also more successful on a per customer basis. The average ACV for our 2017 new customers were slightly higher than in 2016, indicating that we maintained a deal quality as we captured more customers. We also raised our average revenue per customer to $496,000. Finally, for the past three years, we maintained an LTV to CAC ratio above seven. We showed value quickly and we gained quick upsells. For example, there's a large U.S. bank who bought our software last September. We delivered their first application within five weeks. As a result, they expanded their investment in Appian with a multi-million purchase of just three months following their initial quarter. In our judgment, the market opportunity combined with Appian's demonstrated ability to reach and satisfy that market wants an incremental increase in investment in 2018. As you may know, investment is not Appian's first instinct even in a growing market. We broke even roughly on a cash flow basis from the day we were founded to our IPO last May. We are instinctively frugal. We plan a $10 million acceleration in our expenditures for 2018 and our justification for this is as follows: first, our market shows high growth potential, we grew full-year subs revenue 38%, and we more than tripled our rate of new logo acquisition in 2017; second, our technology creates good outcomes and our customers are happy. Here I cite our 122% in RR and our high LTV CAC ratio; third and finally, we are more able to serve and sustain growth in the business than we were before thanks to a higher profile and greater partner support. Due to these factors, we believe now is an opportune time for a reasonable level of additional investment. With that, I'll turn the call over to Mark for a deeper discussion of our financials. Mark?